Glaucoma News and Research

Latest Glaucoma News and Research

Study could provide novel treatment strategy for potentially blinding problem

An enzyme known to help our liver get rid of ammonia also appears to be good at protecting our retina, scientists report.

8 Nov 2018

Genetic inhibition of SARM1 prevents axonal degeneration in nervous systems

Disarm Therapeutics, a biotechnology company creating a new class of disease-modifying therapeutics for patients with axonal degeneration, a central driver of neurological disease, today announced data demonstrating that genetic inhibition of SARM1 prevents axonal degeneration in the central, ocular and peripheral nervous systems.

5 Nov 2018

Researchers find a class of drug that could be promising treatment for uveitis

Ocular inflammation uveitis is a serious disease that can destroy eye tissue and cause irreversible blindness.

2 Nov 2018

Lab-created mini retinas allow researchers to understand retinal ganglion cell development

IUPUI biologists are growing 'mini retinas' in the lab from stem cells to mimic the growth of the human retina. The researchers hope to use the research to restore sight when critical connections between the eye and the brain are damaged.

25 Oct 2018

Potential new biomarkers may aid early detection of glaucoma

Researchers at Ruhr-Universität Bochum have identified new potential biomarkers that may facilitate early detection of glaucoma in patients. Moreover, they ascertained that the mutation of a certain gene in mice causes intraocular pressure elevation.

25 Oct 2018

Immunotherapy medicine found to be effective in treating uveitis

A team of researchers from the UCH CEU's Biomedical Sciences Institute has tested the efficiency of Bevacizumab, medicine used against cancer and in ophtalmology, to treat uveítis, thus stopping the inflammation from spreading.

19 Oct 2018

Fight for Sight chooses World Sight Day 2018 to announce funding for glaucoma research

Fight for Sight has chosen World Sight Day 2018 to announce funding for a research project that will develop personalized medicine for patients at risk of glaucoma from steroid use.

12 Oct 2018

Color-changing contact lens could help doctors to monitor eye disease medications

For all the good they do, eye drops and ointments have one major drawback: It's hard to tell how much of the medication is actually getting to the eye.

11 Oct 2018

Bioaxone Biosciences receives Fast-Track SBIR grant to assess potential of Rho Kinase 2 inhibitor

BioAxone BioSciences, Inc. announced today the receipt of a Fast-Track grant from the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, as part of the agency's Small Business Innovation Research Program.

27 Sep 2018

Your Vision Matters: How to Protect Your Eyesight

Dr. Neil Ebenezer from the charity Fight for Sight discusses the steps you can take to protect your eyesight into old age, and why research into ophthalmic diseases is desperately needed.

24 Sep 2018

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

GlaxoSmithKline plc and Innoviva, Inc. announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has issued a positive opinion today supporting the use of Trelegy Ellipta in a broader group of patients with moderate to severe chronic obstructive pulmonary disease and that labeling, if approved, will be updated to further reflect its effect on exacerbations of COPD.

21 Sep 2018

Multi-year study data shows impact of new soft contact lens to slow myopia progression in children

New four-year study data shows the significant impact of a pioneering contact lens management approach to slowing the progression of myopia (nearsightedness) in children, including those whose treatment begins later.

19 Sep 2018

Alcon expands its global support of eye care professionals through Alcon Experience Academy

Alcon, the global leader in eye care and a division of Novartis, is expanding its extensive, global support of eye care professionals through the unveiling of the Alcon Experience Academy.

18 Sep 2018

Eastenders actress supports awareness campaign on importance of eye tests

Leading eye research charity Fight for Sight has found that nearly three in ten British adults don’t follow the NHS recommendation to have an eye test every two years, and that the majority of this group (74%) say that it’s either because they can’t afford it or because they ‘can see fine’.

11 Sep 2018

Primary care providers could play major role in promoting vision care for older adults

A new poll suggests that primary care providers could play an important role in promoting vision care for adults age 50 and older, especially for those most in need of eye exams, and those most sensitive to the cost.

5 Sep 2018

New system that uses AI accurately detects patients with diabetic retinopathy

A system designed by a University of Iowa ophthalmologist that uses artificial intelligence to detect diabetic retinopathy without a person interpreting the results earned Food and Drug Administration authorization in April, following a clinical trial in primary care offices.

28 Aug 2018

New improved method to judge effectiveness of experimental therapies for neurodegeneration

Researchers at UBC's Okanagan campus have developed a new and improved method to judge the effectiveness of experimental therapies for neurodegeneration--the progressive loss of neurons.

27 Aug 2018

Less-invasive options are slowing disease progression in glaucoma patients

Judith Smith, now 71, was at a routine appointment several years ago with her longtime ophthalmologist when the doctor made a comment that her right eye looked a little suspicious for glaucoma, an incurable disease that occurs when the optic nerve is damaged by pressure building inside the eye.

17 Aug 2018

Mount Sinai study could transform treatment for patients with retinal degenerative diseases

Researchers at Mount Sinai have successfully restored vision in mice through activating retinal stem cells, something that has never been done before. Their study, published in the August 15 online issue of Nature, could transform treatment for patients with retinal degenerative diseases, which currently have no cure.

16 Aug 2018

Connection between Alzheimer’s disease and degenerative eye diseases

According to a new study from the University of Washington School of Medicine there could be an association between Alzheimer’s disease (AD) and three types of degenerative eye diseases.

13 Aug 2018

Glaucoma News and Research

Latest Glaucoma News and Research

Study could provide novel treatment strategy for potentially blinding problem

Genetic inhibition of SARM1 prevents axonal degeneration in nervous systems

Researchers find a class of drug that could be promising treatment for uveitis

Lab-created mini retinas allow researchers to understand retinal ganglion cell development

Potential new biomarkers may aid early detection of glaucoma

Immunotherapy medicine found to be effective in treating uveitis

Fight for Sight chooses World Sight Day 2018 to announce funding for glaucoma research

Color-changing contact lens could help doctors to monitor eye disease medications

Bioaxone Biosciences receives Fast-Track SBIR grant to assess potential of Rho Kinase 2 inhibitor

Your Vision Matters: How to Protect Your Eyesight

CHMP issues positive opinion supporting use of Trelegy Ellipta in broader group of COPD patients

Multi-year study data shows impact of new soft contact lens to slow myopia progression in children

Alcon expands its global support of eye care professionals through Alcon Experience Academy

Eastenders actress supports awareness campaign on importance of eye tests

Primary care providers could play major role in promoting vision care for older adults

New system that uses AI accurately detects patients with diabetic retinopathy

New improved method to judge effectiveness of experimental therapies for neurodegeneration

Less-invasive options are slowing disease progression in glaucoma patients

Mount Sinai study could transform treatment for patients with retinal degenerative diseases

Connection between Alzheimer’s disease and degenerative eye diseases

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Glaucoma News and Research

Latest Glaucoma News and Research

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Newsletters you may be interested in